Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022

SELL
$22.67 - $28.01 $172,065 - $212,595
-7,590 Closed
0 $0
Q4 2021

Jan 10, 2022

BUY
$24.13 - $32.63 $14,478 - $19,578
600 Added 8.58%
7,590 $209,000
Q3 2021

Oct 21, 2021

BUY
$29.97 - $36.66 $209,490 - $256,253
6,990 New
6,990 $226,000
Q3 2021

Oct 13, 2021

SELL
$29.97 - $36.66 $211,887 - $259,186
-7,070 Closed
0 $0
Q2 2021

Jul 21, 2021

BUY
$25.39 - $32.61 $2,031 - $2,608
80 Added 1.14%
7,070 $216,000
Q1 2021

Apr 15, 2021

BUY
$19.92 - $31.6 $139,240 - $220,884
6,990 New
6,990 $213,000
Q2 2019

Jul 09, 2019

SELL
$22.67 - $35.0 $155,470 - $240,030
-6,858 Closed
0 $0
Q1 2019

May 02, 2019

SELL
$26.93 - $34.7 $807 - $1,041
-30 Reduced 0.44%
6,858 $228,000
Q4 2018

Jan 31, 2019

SELL
$27.23 - $45.56 $222,196 - $371,769
-8,160 Reduced 54.23%
6,888 $200,000
Q3 2018

Nov 08, 2018

SELL
$37.57 - $50.34 $5,635 - $7,551
-150 Reduced 0.99%
15,048 $692,000
Q2 2018

Jul 31, 2018

BUY
$27.75 - $40.17 $15,540 - $22,495
560 Added 3.83%
15,198 $568,000
Q1 2018

Apr 16, 2018

SELL
$28.83 - $41.01 $62,215 - $88,499
-2,158 Reduced 12.85%
14,638 $433,000
Q4 2017

Feb 05, 2018

SELL
$28.45 - $37.14 $37,041 - $48,356
-1,302 Reduced 7.19%
16,796 $577,000
Q3 2016

Oct 25, 2017

BUY
N/A
18,098
18,098 $655,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.25B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.